When Should A Contract Manufacturer Or 3PL Register For FDA Drug Establishment Registration?

FDA Drug Establishment Registration FDA registration for covered establishments engaged in manufacturing, repacking, relabeling, or salvaging drugs for U.S. distribution. Deciding whether a contract manufacturer, co-packer, or third‑party logistics provider (3PL) must register depends on the specific activities performed at the site.

For operations teams and compliance managers, the critical question is activity-based: does the site perform any covered operations (manufacture, repack, relabel, salvage)? If yes, registration is required. If the site merely stores sealed, labeled packages without altering them, registration may not be necessary; however, documentation demonstrating the nature of the activity is essential to defend that position in an inspection.

Common Contract Manufacturing And 3PL Scenarios

• Full Manufacture: Facilities that synthesize, formulate, fill, or otherwise produce drug products must register.
• Repacking And Relabeling: Any repacking (breaking bulk and repackaging into new containers) or relabeling (changing label information or adding new labels) generally triggers registration.
• Quality-Control Activities: Sites that perform QA testing or stability studies may still need to register if those activities are part of preparation or processing functions tied to the product.
• Pure Storage/Distribution: Warehouses that only store finished, labeled product and do not perform repacking or relabeling are typically not required to register as drug establishments, but they should maintain clear SOPs and client agreements documenting their limited role.

Foreign Facilities And U.S. Agent Requirements

Foreign contract manufacturers and repackers intended to supply the U.S. market must register with the FDA and designate a U.S. agent. The U.S. agent serves as the FDA’s point of contact for communications and inspection coordination. Ensuring a properly designated U.S. agent is part of the registration checklist for any non-U.S. establishment.

Contractual And Operational Controls To Manage Registration Risk

• Define Activities In Contracts: Clearly document in service agreements whether the 3PL or contract manufacturer will perform repacking, relabeling, or any form of product alteration.
• Assign Regulatory Roles: Designate which party is responsible for registration submissions, product listing, and maintenance of records.
• Audit And Oversight: Conduct periodic audits to verify the facility’s activities match its registration and that the registration is current and accurate.
• Documentation Trail: Keep SOPs, bills of lading, and work orders that prove the scope of activities performed in case of an FDA inquiry.

Operational Checklist Before Assuming A New 3PL Or Contract Packager

Before shifting production or warehousing to a new provider, confirm these items:

• Registration Status: Does the prospective partner have an active FDA registration for the facility and operations you require?
• FEI And Listing Alignment: Are the facility’s FEI and the product listings properly linked to the manufacturer or repacker role?
• U.S. Agent (If Foreign): Is a U.S. agent designated and contactable?
• Change Management: How will you notify FDA of changes (new contract lines, new labels, additional products)?

Example: Relabeling At A 3PL

If a 3PL applies a customer’s new label to sealed bottles (for example, to add local distributor information) the 3PL is performing relabeling and must register. The product owner must list the product and identify that 3PL in the product listing. Both parties should document responsibilities for label control, lot tracking, and adverse event reporting.

In short, the FDA Drug Establishment Registration obligation applies when a contract manufacturer or 3PL performs covered activities such as manufacturing, repacking, relabeling, or salvaging drugs for U.S. distribution; determining and documenting who registers—and keeping registrations and product listings aligned—are essential steps for compliant operations.